Israel vs South-Eastern Asia: Proportion of the target population who received 3 doses of
Israel
98.0%
in 2024
South-Eastern Asia
80.0%
in 2024
Israel rank
23rd
South-Eastern Asia rank
22nd
Proportion of the target population who received 3 doses of over time
- Israel
- South-Eastern Asia
How they compare
Israel currently reports 98.0% against 80.0% in South-Eastern Asia, a difference of 18.0%.
That makes Israel's figure about 1.2 times South-Eastern Asia's.
Across all 25 years both countries report, Israel has been ahead every year.
Israel ranks 23rd and South-Eastern Asia ranks 22nd of 209 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.6% | 81.7% | 11.9% | Israel |
| 2010s | 95.7% | 87.2% | 8.5% | Israel |
| 2020s | 98.0% | 80.6% | 17.4% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received 3 doses of, Israel or South-Eastern Asia?
- Israel, at 98.0% against 80.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received 3 doses of between Israel and South-Eastern Asia?
- 18.0%, with Israel ahead.
- How many years of comparable data are there for Israel and South-Eastern Asia?
- 25 years are reported by both, from 2000 to 2024.
- How do Israel and South-Eastern Asia rank globally for proportion of the target population who received 3 doses of?
- Israel ranks 23rd and South-Eastern Asia ranks 22nd of 209 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.